Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease

Abstract

The invention provides improved agents and methods for treatment of diseases associated with synucleinopathic diseases, including Lewy bodies of alpha-synuclein in the brain of a patient. Such methods entail administering agents that induce a beneficial immunogenic response against the Lewy body. The methods are particularly useful for prophylactic and therapeutic treatment of Parkinson's disease.


Claims
Download PDF
Document Preview
Document History
  • Publication: Apr 3, 2012
  • Application: Feb 22, 2008
    US US 52843908 A
  • Priority: Feb 22, 2008
    US US 52843908 A
  • Priority: Feb 22, 2008
    US US 2008/0002392 W
  • Priority: Nov 1, 2007
    US US 98472107 P
  • Priority: Apr 6, 2007
    US US 69764607 A
  • Priority: Feb 23, 2007
    US US 71024807 A

Download Citation


Sign in to the Lens

Feedback